当前位置: 首页 > 期刊 > 《现代医学》 > 2011年第1期 > 正文
编号:12140027
老年冠心病患者血清胆红素和超敏C反应蛋白水平的变化分析(3)
http://www.100md.com 2011年2月1日 王瑞涛 孟松艳 杨奕 李颖
    参见附件(12kb)。

     [8] SCHWERTHER H A, JACKSON W G, TOLAN G.Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J]. Clin Chem,1994,40(1):18-23.

    [9] TROUGHTON J A, WOODSIDE J V, YOUNG I S, et al. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction(PRIME)[J]. Eur J Cardiovasc Prev Rehabil, 2007, 14(1):79-84.

    [10] LLINGER R, BILBAN M, ERAT A, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation[J]. Circulation, 2005, 112(7):1030-1039.

    [11] VITEK L, SCHWERTNER H A. The heme catabolic pathway and its protective effects on oxidative stress mediated diseases[J]. Adv Clin Chem, 2007,43:1-57.

    [12] 杨俊娟,程宇刚,张钧华.胆红素和氧自由基与心血管疾病的关系[J]. 中国动脉硬化杂志,2006,14(8):728-730.

    [13] BASIGLIO C L, ARRIAGA S M, PELUSA F, et al. Complement activation and disease: protective effects of hyperbilirubinaemia[J]. Clin Sci(Lond), 2009,118(2):99-113.

    [14] FERNANDES A, BRITES D. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents[J]. Curr Pharm Des, 2009,15(25):2915-2926.

    [15] 刘娟,任洁,陈丽琴.超敏C反应蛋白与急性冠脉综合征的关系[J]. 现代医学,2009,37(1):14-15.

    [16] ISHIKAWA J, TAMURA Y, HOSHIDE S, et al. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1[J]. Stroke, 2007,38(3):911-917.

您现在查看是摘要介绍页,详见PDF附件(12kb)